Opus Genetics, Inc. (IRD) Operating margin 2019–2025
Opus Genetics, Inc. (IRD) operating margin by fiscal year — reported operating income divided by reported revenue.
-271.9%FY2025 · since FY2019: -139.8% → -271.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -271.9% | +292.8 pp |
| FY2024 | -564.7% | -509.3 pp |
| FY2023 | -55.5% | -101.2 pp |
| FY2022 | 45.7% | +3900.6 pp |
| FY2021 | -3854.8% | — |
| FY2019 | -139.8% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice